Brent Saunders has more than 25 years of experience in various aspects of health care and has been in leadership roles at several prominent global pharmaceutical and health care companies. Mr. Saunders rejoined Bausch + Lomb as Chief Executive Officer and Chairman of the Board of Directors in March 2023. He previously was cofounder and Chairman of the Board of Vesper Healthcare Acquisitions Corp. Prior to that, he served as Chairman, President and CEO of Allergan plc. His role as President and CEO of Allergan began in 2014 and his added role of Chairman of the Board of Directors began in 2016; he held these roles until 2020 when Allergan was acquired by AbbVie Inc. Mr. Saunders’ first role as an executive officer in the pharmaceuticals and health care sector began in 2003, as a member of the executive management team at Schering-Plough Corporation, where he held several key roles, including President of Schering-Plough’s Global Consumer Health Care division. While there, he led the integration of the company’s acquisition of Organon Biosciences N.V. in 2007, as well as the merger between Schering-Plough and Merck & Co., Inc. in 2009. From 2010 until 2013, he served as CEO of Bausch + Lomb until the company’s acquisition by Bausch Health Companies Inc. (then known as Valeant Pharmaceuticals, Inc.). He then became President and CEO and served as a director of Forest Laboratories Inc., a role he held until that company’s merger with Actavis plc in 2014. Following the merger with Actavis, he was named CEO of the combined business. In 2015, he led Actavis’ acquisition of Allergan, renaming the combined company Allergan Plc. Early in his career, Mr. Saunders was a partner and head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care, Inc. and Senior Vice President of Compliance, Legal and Regulatory at Home Care Corporation of America. He began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Mr. Saunders also serves as Chairman of the Board of The Beauty Health Company, as well as Roam.

Source: Bausch + Lomb Corporation on 07/13/2023